NCT06962813View on ClinicalTrials.gov

Transdermal Radiofrequency V ERASER Versus Polidocanol Sclerotherapy for Reticular Veins and Telangiectasias

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

January 2, 2025

Study Completion Date

April 10, 2025

Conditions
Varicose Veins LegTelangiectasias
Interventions
PROCEDURE

Radiofrequency V Eraser

standar of care sclerotherapy

Trial Locations (1)

02276-140

Hospital São Luiz Gonzaga and Hospital da Irmandade Santa Casa de Misericórdia de São Paulo, São Paulo

All Listed Sponsors
lead

Science Valley Research Institute

OTHER